17.17
-0.285(-1.63%)
Currency In USD
| Previous Close | 17.45 |
| Open | 17.45 |
| Day High | 17.34 |
| Day Low | 17.06 |
| 52-Week High | 21 |
| 52-Week Low | 5.55 |
| Volume | 101,738 |
| Average Volume | 532,858 |
| Market Cap | 761.16M |
| PE | -74.63 |
| EPS | -0.23 |
| Moving Average 50 Days | 17.93 |
| Moving Average 200 Days | 13.19 |
| Change | -0.28 |
If you invested $1000 in AxoGen, Inc. (AXGN) 10 years ago, it would be worth $5,281.54 as of March 13, 2025 at a share price of $17.165. Whereas If you bought $1000 worth of AxoGen, Inc. (AXGN) shares 5 years ago, it would be worth $1,611.74 as of March 13, 2025 at a share price of $17.165.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Axogen, Inc. To Host Analyst & Investor Day on March 4th
GlobeNewswire Inc.
Feb 25, 2025 12:10 PM GMT
ALACHUA, Fla. and TAMPA, Fla., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, will hold its Analyst & Investor Day on March 4,
Axogen, Inc. to report 2024 fourth quarter and full year financial results on February 25, 2025
GlobeNewswire Inc.
Feb 11, 2025 9:58 PM GMT
ALACHUA, Fla. and TAMPA, Fla., Feb. 11, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced that it will report 2024 fourth q
Axogen Announces Appointment of Jesse Bishop as Vice President of Regulatory Affairs and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Feb 03, 2025 1:00 PM GMT
ALACHUA, Fla. and TAMPA, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced the appointment of Jesse Bishop a